Randomized clinical trials and recent patterns in the use of statins

American Heart Journal

Volumn 141, Issue 6, 2001, Pages 957-963

  Wang, Thomas J ^b   Stafford, Randall S ^a   Ausiello, John C ^b   Chaisson, Christine E ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; PROBUCOL; RESIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESEARCH; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035371362     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.115587     Document Type: Article

References (40)

1. National Center for Health Statistics. Health, United States, 1998 with socioeconomic status and health chartbook. Hyattsville (MD): The Center; 1998.
2. Gould AL, Rossouw JE, Santanello NC, et al. Cholesterol reduction yields clinical benefit: a new look at old data. Circulation 1995; 91:2274-82.
3. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. BMJ 1994;308:367-73.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Report of the National Cholesterol Education Program. Arch Intern Med 1988;148:36-69.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
6. Schucker B, Wittes JT, Santanello NC, et al. Changes in cholesterol awareness and action: results from national physician and public surveys. Arch Intern Med 1991;151:666-73.
7. Nieto FJ, Alonso J, Chambless LE, et al. Population awareness and control of hypertension and hypercholesterolemia: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1995;155:677-84.
8. Pieper RM, Arnett DK, McGovern PG, et al. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992: the Minnesota Heart Survey. Arch Intern Med 1997;157:2326-32.
9. Giles WH, Ande RF, Jones DH, et al. Recent trends in the identification and treatment of high blood cholesterol by physicians: progress and missed opportunities. JAMA 1993;269:1133-8.
10. Gotto AM. Cholesterol management in theory and practice. Circulation 1997;96:4424-30.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
12. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
13. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
14. National Center for Health Statistics. Public use data tape documentation: 1980 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1982.
15. National Center for Health Statistics. Public use data tape documentation: 1981 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1984.
16. National Center for Health Statistics. Public use data tape documentation: 1985 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1987.
17. National Center for Health Statistics. Public use data tape documentation: 1989 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1992.
18. National Center for Health Statistics. Public use data tape documentation: 1991 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1993.
19. National Center for Health Statistics. Public use data tape documentation: 1992 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1994.
20. National Center for Health Statistics. Public use data tape documentation: 1993 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1995.
21. National Center for Health Statistics. Public use data tape documentation: 1995 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1997.
22. National Center for Health Statistics. Public use data tape documentation: 1996 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1998.
23. National Center for Health Statistics. Public use data tape documentation: 1997 National Ambulatory Medical Care Survey. Hyattsville (MD): National Center for Health Statistics, US Public Health Service; 1999.
24. National Center for Health Statistics. National Ambulatory Medical Survey, 1998: public-use data file and documentation. Available at ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/. 2000.
25. Potthoff RF, Woodbury MA, Manton KG. "Equivalent sample size" and "equivalent degrees of freedom" refinements for inference using survey weights under superpopulation models. J Am Stat Assoc 1992;87:383-96.
26. Escarce JJ, Chen W, Schwartz JS. Falling cholecystectomy thresholds since the introduction of laparoscopic cholescystectomy. JAMA 1995;273:1581-5.
27. Soumerai SB, Avorn J, Ross-Degnan D, et al. Payment restrictions for prescription drugs under Medicaid: effects of therapy, cost, and equity. N Engl J Med 1987;317:550-6.
28. SAS Institute. SAS/ETS user's guide, version 6. 2nd ed. Cary (NC): SAS Institute; 1993.
29. Kmenta J. Elements of econometrics. Ann Arbor: University of Michigan Press; 1997.
30. Santinga JT, Rosman HS, Rubenfire M, et al. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia. Am J Med 1994;96:509-15.
31. Lansberg PJ, Mitchel YB, Shapiro D, et al. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Atherosclerosis 1995;116:153-62.
32. IMS-America. Total promotion reports 1997: report TPR-2. Plymouth Meeting (PA): IMS-America; 1998.
33. LeMaitre RN, Furberg CD, Newman AB, et al. Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. Arch Intern Med 1998;158:1761-8.
34. Siegel D, Lopez J, Meier J. Use of cholesterol-lowering medications in the United States from 1991 to 1997. Am J Med 2000;108: 496-9.
35. Baxter C, Jones R, Corr L. Time trend analysis and variations in prescribing lipid lowering drugs in general practice. BMJ 1998;317: 1134-5.
36. Lamas GA, Pfeffer MA, Hamm P, et al. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med 1992;327:241-7.
37. Col NF, McLaughlin TJ, Soumerai SB, et al. The impact of clinical trials on the use of medications for acute myocardial infarction: results of a community-based study. Arch Intern Med 1996;156: 54-60.
38. Fineberg HV. Clinical evaluation: how does it influence medical practice? Bull Cancer 1987;74:333-46.
39. McCormick D, Gurwitz JH, Lessard D, et al. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction. Arch Intern Med 1999;159:561-7.
40. Ayanian JZ, Hauptman PJ, Guadagnoli E, et al. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994;331: 1136-42.